Emma Searle

4PUBLICATIONS
6CO-AUTHORS
Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 02, 2025
A phase 1, first-in-human, dose-escalation study of JNJ-74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS.

Emma Searle, Thomas Cluzeau, Jenny O'Nions

|Jan 31, 2025
Improvement in cutaneous disease with menin inhibitor monotherapy in KMT2A rearranged AML.

John Chadwick, Karen Rees-Unwin, Valarmathi Anandhan

|Nov 02, 2022
Targeting hypoxia in solid and haematological malignancies.

Bill Harris, Sana Saleem, Natalie Cook

|Nov 01, 2017
Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironment.

Emma J Searle, Brian A Telfer, Debayan Mukherjee

Pageof 1

Frequent Collaborators

1 joint publications

Tim M Illidge

1 joint publications

Thomas Cluzeau

1 joint publications

Jenny O'Nions

1 joint publications

Emmanuel Gyan